Cannabis in the News, Hemp, Investment Opportunities, Research, Science
Hemp, Inc. Launching New Cannabinoids after Recent Hemp/Covid Study Hemp, Inc. will be launching a CBDA and CBGA line as its primary cannabinoids. Oregon State University’s (OSU) recent study found hemp compounds could prevent a Covid-19 infection. “This not...
Cannabis in the News, Research, Science
Research: CannaboBreast Products Kill Cancer Cells in Patients The composition of cannabinoids and mushrooms in combination with standard chemotherapy improved the effectiveness in killing cancer cells from 10% mortality to 60% mortality New medical research conducted...
Cannabis in the News, Research, Science, Technology/Innovations
Lexaria Bioscience Pursuing Regulatory Approvals for DehydraTECH CBD Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. Related: Should You...
Cannabis in the News, Science, Technology/Innovations
Lexaria Bioscience CBD Study Results Expected to Demonstrate Effectiveness Against Hypertension Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its human clinical study HYPER-H21-3 is expected to complete...
Cannabis in the News, Health, Psychedelic Stocks, Science
Magic mushrooms, also referred to as shrooms, have received a lot of criticism in the past. Fortunately, the clouds of uncertainty have been waved off, especially after many researchers have backed magic mushrooms. But are magic mushrooms really the next best health...
Cannabis in the News, CBD Stocks, Finance, Investment Opportunities, marijuana stock, Science, Stock Talk
We continue to see plenty of chatter on social media about Claritas Pharmaceuticals so we figured we would go ahead and do a deep dive fundamental analysis on the company. But is Claritas Pharmaceuticals a good investment? Let’s take a closer look at the...